70502-82-8|Traxanox sodium|5H-(1)Benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1H-tetrazol-5-yl)-, sodium salt|-范德生物科技公司

Traxanox sodium

NMR下载 COA and HPLC MSDS下载
names：
5H-(1)Benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1H-tetrazol-5-yl)-, sodium salt
CAS号：
70502-82-8
MDL Number：
MF(分子式)： C13H5ClN5NaO2 MW(分子量)： 321.6558
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	5H-(1)Benzopyrano(2,3-b)pyridin-5-one, 9-chloro-7-(1H-tetrazol-5-yl)-, sodium salt
英文别名	Traxanox sodium; Y 12141; Y-12141; Y12141.
CAS号	70502-82-8
SMILES	n1nnc(c2cc3c(oc4c(c3=O)cccn4)c(Cl)c2)[n-]1.[Na+]
Inchi	InChI=1S/C13H5ClN5O2.Na/c14-9-5-6(12-16-18-19-17-12)4-8-10(20)7-2-1-3-15-13(7)21-11(8)9;/h1-5H;/q-1;+1
InchiKey	LAEVCGNXDKGJQI-UHFFFAOYSA-N
分子式 Formula	C13H5ClN5NaO2
分子量 Molecular Weight	321.6558
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Traxanox sodium(CAS:70502-82-8):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Traxanox sodium is a biochemical.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Fujimura A, Ebihara A, Hino N, Koike Y. Effects of traxanox sodium on blood pressure and serum uric acid in hypertensive patients: a preliminary study. J Clin Pharmacol. 1989 Apr;29(4):327-30. PubMed PMID: 2723121.

[2]Hisadome M, Terasawa M, Goto K, Kawazoe Y, Okumoto T. Stimulation of phagocytic activity of leukocytes and macrophages by traxanox sodium in mice and rats. Jpn J Pharmacol. 1989 Feb;49(2):275-84. PubMed PMID: 2733265.

[3] Terasawa M, Tomomatsu N, Maruyama Y. [Effects of traxanox sodium on experimental nasal allergy]. Nihon Yakurigaku Zasshi. 1988 Jul;92(1):11-6. Japanese. PubMed PMID: 3220322.

[4] Ebihara A, Tsuru M, Ohashi K, Fujimura A, Kondo K. Diuretic and uricosuric effects of traxanox sodium in healthy subjects. Single dose study. Arzneimittelforschung. 1987 Dec;37(12):1388-91. PubMed PMID: 3329516.

[5] Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol. 1987 Feb;90(2):421-9. PubMed PMID: 2435353; PubMed Central PMCID: PMC1916952.

6: Terasawa M, Imayoshi T, Maruyama Y, Abe C. [Effect of traxanox sodium on inflammatory response]. Nihon Yakurigaku Zasshi. 1985 Nov;86(5):329-40. Japanese. PubMed PMID: 2867959.7: Terasawa M, Imayoshi T, Goto K. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis]. Nihon Yakurigaku Zasshi. 1983 Jul;82(1):93-101. Japanese. PubMed PMID: 6194083.8: Nakamura T, Miura Y, Aihara K, Satoh H, Goto K, Tsumagari T. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system]. Nihon Yakurigaku Zasshi. 1983 Jul;82(1):79-92. Japanese. PubMed PMID: 6137441.9: Goto K, Osuga K, Haga K, Tsumagari T. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system]. Nihon Yakurigaku Zasshi. 1983 May;81(5):343-63. Japanese. PubMed PMID: 6629211.10: Ikegami K, Hirano S, Hasegawa G. The effects of traxanox sodium of cyclic AMP phosphodiesterase and the concentration of cyclic AMP in the plasma of rats. Chem Pharm Bull (Tokyo). 1983 Feb;31(2):752-5. PubMed PMID: 6309423.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开